SG Americas Securities’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,556
Closed -$390K 3847
2024
Q4
$390K Buy
31,556
+6,739
+27% +$77.2K ﹤0.01% 1567
2024
Q3
$282K Buy
+24,817
New +$249K ﹤0.01% 2206
2024
Q1
Sell
-56,989
Closed -$370K 3547
2023
Q4
$370K Buy
+56,989
New +$367K ﹤0.01% 1664
2022
Q3
Sell
-29,433
Closed -$449K 3633
2022
Q2
$449K Buy
29,433
+17,780
+153% +$263K ﹤0.01% 2050
2022
Q1
$237K Buy
+11,653
New +$237K ﹤0.01% 2331
2021
Q4
Sell
-20,976
Closed -$452K 3883
2021
Q3
$452K Sell
20,976
-23,154
-52% -$559K ﹤0.01% 2599
2021
Q2
$1.13M Buy
44,130
+34,326
+350% +$733K 0.01% 1487
2021
Q1
$179K Buy
+9,804
New +$163K ﹤0.01% 2747
2020
Q3
Sell
-31,284
Closed -$205K 3575
2020
Q2
$205K Buy
31,284
+10,634
+51% +$59.4K ﹤0.01% 2845
2020
Q1
$106K Buy
+20,650
New +$125K ﹤0.01% 2967
2019
Q3
Sell
-177,536
Closed -$994K 3260
2019
Q2
$994K Sell
177,536
-13,213
-7% -$54.5K 0.01% 1435
2019
Q1
$811K Buy
190,749
+8,956
+5% +$36.5K 0.01% 1447
2018
Q4
$745K Buy
181,793
+5,825
+3% +$30.4K 0.01% 1563
2018
Q3
$1.21M Buy
+175,968
New +$1.04M 0.01% 1553
2016
Q2
Sell
-22,746
Closed -$67K 3048
2016
Q1
$67K Buy
+22,746
New +$122K ﹤0.01% 2719
2015
Q4
Sell
-6,324
Closed -$45K 3034
2015
Q3
$45K Buy
+6,324
New +$52.8K ﹤0.01% 1973
2014
Q4
Sell
-11,387
Closed -$108K 3414
2014
Q3
$108K Buy
+11,387
New +$127K ﹤0.01% 2343
2013
Q4
Sell
-4,107
Closed -$41K 3070
2013
Q3
$41K Buy
+4,107
New +$40.8K ﹤0.01% 2818

Other funds holding CDMO

SG Americas Securities's CDMO Position: Q1 2025 in Review

SG Americas Securities sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 31,556 shares — an estimated $390K sold.

SG Americas Securities first reported a position in CDMO in Q3 2013 and held it in 18 quarters. The position peaked at $1.21M in Q3 2018. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • SG Americas Securities reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • SG Americas Securities sold 31,556 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $390K.
  • SG Americas Securities first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2013 and held it in 18 quarters.
  • SG Americas Securities's Avid Bioservices, Inc. Common Stock position peaked at $1.21M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.